Zhao Daqiang, Zhu Lan, Zhang Shengyuan, Guo Zhiliang, Wang Lu, Pan Tianhui, Sa Rula, Chen Zhishui, Jiang Jipin, Chen Gang
Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, Ministry of Public Health, Chinese Academy of Medical Sciences, Wuhan, China.
Front Med (Lausanne). 2022 Mar 2;9:838738. doi: 10.3389/fmed.2022.838738. eCollection 2022.
ABO blood group antibodies have not been generated or are at low titer during early infancy. Therefore, in theory, ABO-incompatible kidney transplantation (ABOi KT) may be successfully achieved in small infants without any pre-transplant treatment. We report here the first ABO-incompatible deceased donor kidney transplantation (ABOi DDKT) in an infant. The recipient infant was ABO blood group O, and the donor group A. The recipient was diagnosed with a Wilms tumor gene 1 (WT1) mutation and had received peritoneal dialysis for 4 months prior to transplant. At 7 months and 27 days of age, the infant underwent bilateral native nephrectomy and single-kidney transplantation from a 3-year-old brain-dead donor. No pre- or post-transplantation antibody removal treatment was performed, since the recipient's anti-iso-hemagglutinin-A Ig-M/G antibody titers were both low (1:2) before transplantation and have remained at low levels or undetectable to date. At 11 months post-transplant, the recipient is at home, thriving, with normal development and graft function. This outcome suggests that ABOi DDKT without antibody removal preparatory treatment is feasible in small infants, providing a new option for kidney transplantation in this age range.
ABO血型抗体在婴儿早期尚未产生或滴度较低。因此,从理论上讲,在未进行任何移植前治疗的小婴儿中,ABO血型不相容肾移植(ABOi KT)可能会成功实现。我们在此报告首例婴儿ABO血型不相容的脑死亡供体肾移植(ABOi DDKT)。受体婴儿为O型血,供体为A型血。受体被诊断出患有威尔姆斯瘤基因1(WT1)突变,在移植前已接受了4个月的腹膜透析。在7个月27天大时,该婴儿接受了双侧自体肾切除术,并接受了一名3岁脑死亡供体的单肾移植。由于受体移植前抗A同种血凝素Ig-M/G抗体滴度均较低(1:2),且至今一直维持在低水平或检测不到,因此未进行移植前或移植后抗体清除治疗。移植后11个月,受体在家中茁壮成长,发育正常,移植肾功能良好。这一结果表明,在小婴儿中,不进行抗体清除预处理的ABOi DDKT是可行的,为该年龄范围的肾移植提供了一种新的选择。